Nestle gets US boost from more spending on pets
Zurich
NESTLE SA is getting a boost from US consumers spending more on their pets as economic expansion buoys household finances.
First-quarter sales rose 2.8 per cent on an organic basis, the Vevey, Switzerland-based maker of Purina Dog Chow and KitKat chocolate said on Thursday. Analysts expected 2.5 per cent. The shares rose 0.5 per cent in Zurich.
Chief executive officer Mark Schneider is revamping the world's largest food company around businesses like pet care, coffee and bottled water after jettisoning the US confectionery business and adding healthy food brands. These "deep" changes take time, according to Vontobel analyst Jean-Philippe Bertschy, who expects organic growth to accelerate in coming quarters.
"After several disappointing quarters, Nestle was able to revert the trend and to deliver above market expectations," Mr Bertschy said. "The start of the year looks good for Nestle." In the US, where Nestle generated about a third of its revenue last year, the pet-care business improved amid stronger demand for natural products and increased online sales. Globally, the business accounted for 14 per cent of Nestle's sales last year.
Nestle did not quantify the gains in the US but said that pet care recorded the highest organic growth of any of its main product categories in the first quarter, at 4.7 per cent. Vontobel's Mr Bertschy said pet care was the main growth driver in the US, as it made up about 27 per cent of sales in the country during the quarter.
The American confectionery unit, which Nestle has sold, still weighed on results in the quarter. The company has been wrestling with fast-changing preferences that include a shift to online sales and healthier snack options.
"A return to positive growth in the US is encouraging," James Targett, an analyst at Berenberg, wrote in a note. BLOOMBERG
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Shareholders raise questions over dividend payout, directors’ salaries at Best World AGM ahead of proposed privatisation
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue